Benicar en es it fr

Benicar Brand names, Benicar Analogs

Benicar Brand Names Mixture

  • No information avaliable

Benicar Chemical_Formula


Benicar RX_link

Benicar fda sheet

Benicar FDA

Benicar msds (material safety sheet)

Benicar MSDS

Benicar Synthesis Reference

No information avaliable

Benicar Molecular Weight

558.585 g/mol

Benicar Melting Point

175-180 oC

Benicar H2O Solubility

No information avaliable

Benicar State


Benicar LogP


Benicar Dosage Forms


Benicar Indication

For the treatment of hypertension

Benicar Pharmacology

Olmesartan Medoxomil, a specific angiotensin II type 1 antagonist, is used alone or with other antihypertensive agents to treat hypertension. Unlike the angiotensin receptor antagonist losartan, olmesartan does not have an active metabolite or possess uricosuric effects. Blockade of the angiotensin II receptor inhibits the negative regulatory feedback of angiotensin II on renin secretion, but the resulting increased plasma renin activity and circulating angiotensin II levels do not overcome the effect of olmesartan on blood pressure.

Benicar Absorption

Bioavailability is about 26%. Food does not affect the bioavailability of olmesartan.

Benicar side effects and Toxicity

Symptoms of overdose include dehydration (dry mouth, excessive thirst, muscle pain or cramps, nausea and vomiting, weakness), dizziness, low blood pressure, and slow or irregular heartbeat.

Benicar Patient Information

Benicar Organisms Affected

Humans and other mammals